AstraZeneca and Oxford produced COVID-19 vaccine 70% effective

The jointly-developed vaccine against COVID-19, being produced by British drugs group AstraZeneca and the University of Oxford, on November 23, said that their vaccine has shown 70 per cent efficacy in trials.

In a statement, AstraZeneca chief executive Pascal Soriot, said, “This vaccine’s efficacy and safety confirm that it will be highly effective against Covid-19 and will have an immediate impact on this public health emergency.”

It must be noted that the vaccine has produced lower average efficacy than the rivals Pfizer/BioNTech and Moderna that have come in above 90 per cent.

Photo Credit : https://commons.wikimedia.org/wiki/File:AstraZeneca_HQ_in_Cambridge_UK.jpg